 |
 |
Advancing the Management Of Hereditary Angioedema
Hereditary angioedema (HAE) is a rare but potentially life-threatening genetic disease caused by functional C1-inhibitor (C1-INH) deficiency and characterized by recurrent episodes of severe, localized edema of the skin, gastrointestinal mucosa, and upper respiratory tract that do not respond to treatment with antihistamines or corticosteroids.
To request a free hard copy of this Special Report article, please email your full name, mailing address, and institution to gastroendonews@mcmahonmed.com
AUGUST, 2010 |
|
 |
Advances in Gastrointestinal Stent Technology: Highlights From the 2009 GI Stents Leadership Summit
The application of gastrointestinal stents has expanded significantly in recent years. Biliary, duodenal and esophageal stents may be used as palliative care or as bridge to surgery treatment of several malignant and benign conditions. The following Special Report discusses the clinical experiences of the directors of endoscopy at 3 institutions as presented at the 2009 GI Stents Leadership Summit.
To request a free hard copy of this Special Report article, please email your full name, mailing address, and institution to gastroendonews@mcmahonmed.com
DECEMBER, 2009 |
|
 |
Inflammatory Bowel Disease in Pediatric Patients: Utility of Serologic Testing
An estimated 1.4 million Americans are
diagnosed with inflammatory bowel disease
(IBD) and approximately 10% of these
cases are children or adolescents. Pediatric
Crohn’s disease (CD) is more common than
ulcerative colitis (UC). Pediatric CD is diagnosed
more frequently now than 40 years
ago, with studies conducted in the United
States and Europe documenting increases
in mean overall annual incidence rates.
MAY, 2009 |
|
 |
Management of Irritable Bowel Syndrome With Constipation in Adult Women
Irritable bowel syndrome (IBS) is a multisymptomatic
disorder characterized by abdominal pain associated
with altered bowel habits. According to the Rome III
diagnostic criteria, IBS consists of recurrent abdominal
pain or discomfort that is associated with 2 or more of
the following characteristics: improvement with defecation,
onset associated with a change in stool frequency,
or onset associated with a change in stool form.
MAY, 2009 |
|
See more in the Special Report Archives |
1